{"id":247355,"date":"2026-11-14T11:24:33","date_gmt":"2026-11-14T17:24:33","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/11\/supratentorial-ependymoma-a-comprehensive-review-of-molecular-classification-management-strategies-and-clinical-outcomes-part-ii-of-pediatric-ependymomas-across-compartments-journal-of"},"modified":"2026-11-14T11:24:33","modified_gmt":"2026-11-14T17:24:33","slug":"supratentorial-ependymoma-a-comprehensive-review-of-molecular-classification-management-strategies-and-clinical-outcomes-part-ii-of-pediatric-ependymomas-across-compartments-journal-of","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/11\/supratentorial-ependymoma-a-comprehensive-review-of-molecular-classification-management-strategies-and-clinical-outcomes-part-ii-of-pediatric-ependymomas-across-compartments-journal-of","title":{"rendered":"Supratentorial ependymoma: a comprehensive review of molecular classification, management strategies, and clinical outcomes (Part II of pediatric ependymomas across compartments) \u2014 Journal of Neuro-Oncology"},"content":{"rendered":"\n<p>To review the clinical, molecular, and imaging landscape of pediatric supratentorial ependymoma (ST-EP) and outline current management principles guiding surgical and adjuvant treatment decisions.<\/p>\n<p>Synthesis of literature regarding biology, diagnosis, and management of ST-EP, focusing on recently emerging molecular subtypes.<\/p>\n<p>ST-EP is an important and clinically significant intracranial malignancy comprising roughly 30\u201340% of all ependymoma cases. The 2021 WHO molecular classification stratified ST-EP into ZFTA-fusion, YAP1-fusion, and NEC subtypes, fundamentally altering our understanding of this pathology. ZFTA-fused tumors represent the majority of ST-EP, are seen in older patients and harbor a relatively worse prognosis while YAP1-fused tumors, though rarer, are enriched for younger children and carry a substantially more favorable prognosis. Management of very young children presents a unique therapeutic challenge, balancing disease control against the neurocognitive sequelae of cranial irradiation and aggressive surgery in the developing brain.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>To review the clinical, molecular, and imaging landscape of pediatric supratentorial ependymoma (ST-EP) and outline current management principles guiding surgical and adjuvant treatment decisions. Synthesis of literature regarding biology, diagnosis, and management of ST-EP, focusing on recently emerging molecular subtypes. ST-EP is an important and clinically significant intracranial malignancy comprising roughly 30\u201340% of all ependymoma [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-247355","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/247355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=247355"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/247355\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=247355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=247355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=247355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}